Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer
Clinical trial NCT05942768 · COMPLETED
Trial details
- NCT number
- NCT05942768
- Sponsor
- Hunan Cancer Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-07-01
- Primary completion
- 2021-06-30
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.